rs767576877
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_001161352.2(KCNMA1):c.469G>C(p.Gly157Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G157S) has been classified as Uncertain significance.
Frequency
Genomes: not found (cov: 32)
Consequence
KCNMA1
NM_001161352.2 missense
NM_001161352.2 missense
Scores
6
5
4
Clinical Significance
Conservation
PhyloP100: 7.84
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
?
Very rare variant in population databases, with high coverage;
PP2
?
Missense variant where missense usually causes diseases, KCNMA1
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNMA1 | NM_001161352.2 | c.469G>C | p.Gly157Arg | missense_variant | 2/28 | ENST00000286628.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNMA1 | ENST00000286628.14 | c.469G>C | p.Gly157Arg | missense_variant | 2/28 | 1 | NM_001161352.2 | A2 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 genomes
?
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome ? Cov.: 32
GnomAD4 genome
?
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Generalized epilepsy-paroxysmal dyskinesia syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 03, 2017 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with KCNMA1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with arginine at codon 157 of the KCNMA1 protein (p.Gly157Arg). The glycine residue is moderately conserved and there is a moderate physicochemical difference between glycine and arginine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
D;D;D;D;D;D;D
PrimateAI
Pathogenic
D
Sift4G
Uncertain
D;.;.;.;.;.;.;.;T;.;.;.;.;.;.;.;T;.;T;.;.;.;.;.;.;.;.;.;.;.;.;.;T;T;.;.;.;.;.;.;.;T;.;.;.;.
Polyphen
0.99, 1.0, 1.0, 1.0
.;.;.;.;.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;D;.;.;.;.;D;.;.;D;.;.;.;.
Vest4
0.94, 0.96, 0.94, 0.95, 0.96, 0.96
MutPred
0.43
.;Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);.;Gain of MoRF binding (P = 0.0091);.;Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);.;.;Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);.;.;.;.;.;Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);.;Gain of MoRF binding (P = 0.0091);.;Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);.;Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);Gain of MoRF binding (P = 0.0091);.;Gain of MoRF binding (P = 0.0091);
MVP
MPC
2.6
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at